Picture of Crossject SA logo

ALCJ Crossject SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: Crossject End-Dec Operating Loss Narrows To 8.6 Million Euros

March 26 (Reuters) - Crossject SA  74C.F :
    * 2019 ANNUAL RESULTS AND BUSINESS REVIEW
    * LIKELY IMPACT OF COVID-19 ON SCHEDULE BUT TEAMS REMAIN
OPERATIONAL
    * REDUCTION OF LOSSES THANKS IN PARTICULAR TO COMMERCIAL
ACTIVITIES
    * END-DEC NET LOSS EUR 7.2 MILLION VERSUS LOSS OF EUR 10.7
MILLION
YEAR AGO
    * THE OPERATING LOSS AT DECEMBER 31, 2019 WAS €8.6 MILLION
(COMPARED WITH LOSS OF €11.6 MILLION AT THE END OF 2018)
    * AS OF DEC 31, 2019 INCREASED CASH POSITION OF €7.9 MILLION
VERSUS €4.8 MILLION AT THE END OF 2018
    * ANTICIPATES ADDITIONAL CASH INFLOWS IN THE FINANCIAL YEAR
2020
IN THE FORM OF GRANTS IN THE PROCESS OF BEING CONTRACTED AND
COMMERCIAL INCOME FROM EXISTING OR NEW LICENCE AGREEMENTS
    * END-DEC OPERATING REVENUE EUR 6.0 MILLION VERSUS EUR 3.5
MILLION
YEAR AGO

Source text for Eikon:  ID:nGNE7lWSG7 
Further company coverage:  74C.F 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48587785110;))

Recent news on Crossject SA

See all news